Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non Operating Income (2020 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Non Operating Income for 6 consecutive years, with -$105000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 165.62% to -$105000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$680000.0 through Dec 2025, down 900.0% year-over-year, with the annual reading at -$680000.0 for FY2025, 900.0% down from the prior year.
  • Non Operating Income hit -$105000.0 in Q4 2025 for Harmony Biosciences Holdings, up from -$106000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $193000.0 in Q4 2023 to a low of -$276000.0 in Q1 2025.
  • Historically, Non Operating Income has averaged -$21315.8 across 5 years, with a median of -$2000.0 in 2022.
  • Biggest five-year swings in Non Operating Income: soared 950.0% in 2022 and later crashed 7150.0% in 2024.
  • Year by year, Non Operating Income stood at $31000.0 in 2021, then skyrocketed by 135.48% to $73000.0 in 2022, then soared by 164.38% to $193000.0 in 2023, then fell by 17.1% to $160000.0 in 2024, then tumbled by 165.62% to -$105000.0 in 2025.
  • Business Quant data shows Non Operating Income for HRMY at -$105000.0 in Q4 2025, -$106000.0 in Q3 2025, and -$193000.0 in Q2 2025.